Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome

[21] Xing Y(2019)The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis Sci Rep. 9 7320-291

[22] Zhao D(2019)The triglyceride-glucose index, a predictor of type 2 diabetes development: A retrospective cohort study Prim Care Diabetes. 14 161-undefined

[23] Wiviott SD(2018)The role of triglyceride glucose index in development of Type 2 diabetes mellitus Diabetes Res Clin Pract 143 43-undefined

[24] Braunwald E(2014)Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study PLoS ONE 9 e90430-undefined

[25] McCabe CH(2020)Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome Cardiovasc Diabetol. 19 31-undefined

[26] Montalescot G(2006)Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ 333 1091-undefined

[27] Ruzyllo W(2014)Insulin resistance and hyperglycaemia in cardiovascular disease development Nat Rev Endocrinol. 10 293-undefined

[28] Gottlieb S(2008)Association of insulin resistance with de novo coronary stenosis after percutaneous coronary artery intervention in hemodialysis patients Nephron Clin Pract. 109 c9-undefined

[29] Neumann FJ(2012)Impact of insulin resistance on post-procedural myocardial injury and clinical outcomes in patients who underwent elective coronary interventions with drug-eluting stents JACC Cardiovasc Interv. 5 1159-undefined

[30] Ardissino D(2003)Veterans Affairs HDL Intervention Trial (VA-HIT) Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Afairs HDL Intervention Trial (VA-HIT) Diabetes Care 26 1513-undefined

[21] Xing Y(2019)The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis Sci Rep. 9 7320-291

[22] Zhao D(2019)The triglyceride-glucose index, a predictor of type 2 diabetes development: A retrospective cohort study Prim Care Diabetes. 14 161-undefined

[23] Wiviott SD(2018)The role of triglyceride glucose index in development of Type 2 diabetes mellitus Diabetes Res Clin Pract 143 43-undefined

[24] Braunwald E(2014)Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study PLoS ONE 9 e90430-undefined

[25] McCabe CH(2020)Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome Cardiovasc Diabetol. 19 31-undefined

[26] Montalescot G(2006)Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ 333 1091-undefined

[27] Ruzyllo W(2014)Insulin resistance and hyperglycaemia in cardiovascular disease development Nat Rev Endocrinol. 10 293-undefined

[28] Gottlieb S(2008)Association of insulin resistance with de novo coronary stenosis after percutaneous coronary artery intervention in hemodialysis patients Nephron Clin Pract. 109 c9-undefined

[29] Neumann FJ(2012)Impact of insulin resistance on post-procedural myocardial injury and clinical outcomes in patients who underwent elective coronary interventions with drug-eluting stents JACC Cardiovasc Interv. 5 1159-undefined

[30] Ardissino D(2003)Veterans Affairs HDL Intervention Trial (VA-HIT) Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Afairs HDL Intervention Trial (VA-HIT) Diabetes Care 26 1513-undefined